Towers CV, Pircon A, Heppard M: Is tocolysis safe in the management of third-trimester bleeding? Am ] Obstet Gynecol 180: 1572, 1999 Treloar E], Anderson RS, Andrews HG, et at: Uterine necrosis following B-Lynch suture for primary postpartum haemorrhage. B]OG 113:486,2006
Trudell A, Stout M, Cahill A, et al: Second trimester cervical length and persistence of placental previa in the third trimester. Abstract No. 91, Presented at the 33rd Annual Meeting of the Society for Maternal-Fetl Medicine, February 11-16, 2013
T wielder D M, Lucas M], Balis AB, et al: Color low mapping for myometrial invasion in women with a prior cesarean deliveY. ] Matern Fetal Med 9:330, 2000 Ugwu lA, Oluwasola T A, Enabor 00, et al: Randomized controlled trial comparing 200�g and 400�g sublingual misoprostol for prevention of primary postpartum hemorrhage. Int] Gynaecol Obstet 133(2):173, 2016 Usta 1M, Hobeika EM, Abu Musa A, et al: Placenta previa-accreta: risk factors and complications. Am] Obstet Gynecol 193:1045,n2005 Uszynski M, Zekanowska E, Uszynski W, et al: Tissue factor (TF) and tissue factor pathway inhibitor (TFPI) in amniotic luid and blood plasma: implications for the mechanism of amniotic luid embolism. Eurn] Obstet Gynecol Reprod Bioi 95:163, 2001
Villar], Gi.ilmezoglu AM, Hofmeyr G], et al: Systematic review of randomized controlled trials of misoprostol to prevent postpartum hemorrhage. Obstet Gynecolnl00:1301,n2002
Vintejoux E, Ulrich D, Mousty E, et al: Success factors for Bakri balloon usage secondary to uterine atony: a retrospective, multicenter study. Aust N Z ] Obstet Gynaecol 55(6):572, 2015 Walker MG, Allent L, Windrim RC, et al: Multidisciplinary management of invasive placenta previa.n] Obstet Gynaecol Can 35(5):417, 2013
Wang L, Matsunaga S, Mikami Y, et al: Pre-delivery ibrinogen predicts adverse maternal or neonatal outcomes in patients with placental abruption. ] Obstet Gynaecol Res 42(7):796, 2016
Warshak CR, Eskander R, Hull AD, et al: Accuracy of ultrasonography and magnetic resonance imaging in the diagnosis of placenta accreta. Obstet Gynecol 108(3 Pt 1):573, 2006
Warshak CR, Ramos GA, Eskander R, et al: Efect of predelivery diagnosis in 99 consecutive cases of placenta accreta. Obstet Gynecol 115(1):65,n2010
Wehrum M], Buhimschi lA, Salaia C, et al: Accreta complicating complete placenta previa is characterized by reduced systemic levels of vascular endothelial growth factor and by epithelial-to-mesenchymal transition of the invasive trophoblast. Am] Obstet Gynecol 204(5):411.el, 2011